CN102895599A - Traditional Chinese medical composition for treatment of cirrhosis - Google Patents
Traditional Chinese medical composition for treatment of cirrhosis Download PDFInfo
- Publication number
- CN102895599A CN102895599A CN2012104226811A CN201210422681A CN102895599A CN 102895599 A CN102895599 A CN 102895599A CN 2012104226811 A CN2012104226811 A CN 2012104226811A CN 201210422681 A CN201210422681 A CN 201210422681A CN 102895599 A CN102895599 A CN 102895599A
- Authority
- CN
- China
- Prior art keywords
- parts
- treatment
- parched
- liver cirrhosis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medical composition for treatment of cirrhosis, aiming to solve the problems of treatment of cirrhosis with Western medicine such as poor efficacy, high cost and easy recurrence after drug withdrawal. The traditional Chinese medical composition consists of the following components in parts by weight: 40-80 parts of fried turtle shell, 20-60 parts of fried pangolin, 20-60 parts of eupolyphaga, 20-40 parts of trigone, 20-40 parts of curcuma zedoary, 20-60 parts of peach kernel, 20-50 parts of pseudo-ginseng, 60-100 parts of fried astragalus mongholicus, 40-80 parts of fried rhizoma atractylodis macrocephalae, 20-40 parts of gynostemma pentaphylla, 30-60 parts of colla corii asini, 15-30 parts of liquorice, 15-40 parts of kaladana, 30-60 parts of oldenlandia diffusa and 30-60 parts of radix isatidis. When the traditional Chinese medical composition is applied in treatment of cirrhosis, ascites pumping, surgery and the like are not needed, and pains of patients can be effectively alleviated. Meanwhile, significant efficacy can be achieved, no recurrence can be caused after curing, and the cost is low.
Description
Technical field
The present invention relates to field of medicaments, especially a kind of Chinese medicine composition for the treatment of liver cirrhosis.
Background technology
Liver cirrhosis is a kind of common chronic, carrying out property, DHD that is caused by different pathogeny, its pathological characteristic is widely hepatocellular degeneration and necrosis, fibrous tissue diffusivity hypertrophy, and have the regeneration lesser tubercle to form and the destruction of vascular anatomy, cause liver to be out of shape gradually and harden into liver cirrhosis.Liver cirrhosis clinically in early days can be asymptomatic or symptom is lighter; Hypofunction of liver, portal hypertension and the multisystem various symptoms such as get involved can appear in the later stage, are divided into simultaneously " compensatory phase of liver function " and " liver function is lost the compensatory phase "; The severe complications such as upper gastrointestinal hemorrhage, hepatic encephalopathy, secondary infection, hepatorenal syndrome often appear late period.The Main Basis of liver cirrhosis diagnosis is as follows: (1) has viral hepatitis, schistosomicide, the medical history such as drink for a long time; (2) clinical manifestation of hypofunction of liver and portal hypertension is arranged; (3) the hard nodosity sense of Liver on Judge Hardness; (4) the visible portal vein of ultrasound investigation, Dsv broadening, intraperitoneal had the opaque dark area of fluid when ascites was arranged; (5) x-ray esophageal barium meal radiography and gastroscopy, visible esophagus, angry of gastric fundus vein; (6) liver function test, serum bilirubin have in various degree increases, and (AST, ALT) can have obviously unusual, " TTT " positive, and plasma albumin reduces, and globulin increases, and albumin and globulin ratio are inverted, and protein electrophoresis r globulin obviously increases; (7) liver is worn the visible lobule of biopsy and forms (all have pseudolobuli just can make a definite diagnosis).
At present, doctor trained in Western medicine is for the treatment of liver cirrhosis, main adopt protect the liver, support, ascites treating, cooperate simultaneously the operative treatment of portal hypertension and Complications etc.The curative effect of western medical treatment liver cirrhosis is not good enough, and expense is higher, easily recurrence after the drug withdrawal.
Summary of the invention
Goal of the invention of the present invention is: for doctor trained in Western medicine in treatment during liver cirrhosis, curative effect is not good enough, expense is higher, the problem that easily recurs after the drug withdrawal, a kind of Chinese medicine composition for the treatment of liver cirrhosis is provided, and it passes through the interaction of each component, thereby makes the liver fiber of liver cirrhosis patient eliminate gradually, absorb, the mark such as ascites, jaundice disease can be recovered without treatment, final effectively treatment liver cirrhosis.Adopt traditional Chinese medicine composition for treating liver cirrhosis of the present invention, do not need to tap the abdomen, operation etc., can effectively alleviate the patient suffering, simultaneously, it is evident in efficacy, be difficult for recurrence after curing, and expense is low.
The technical solution used in the present invention is as follows:
A kind of Chinese medicine composition for the treatment of liver cirrhosis is comprised of the component of following weight portion: fry Carapax Trionycis 40-80 part, Squama Manis(parched) 20-60 part, Eupolyphaga Seu Steleophaga 20-60 part, rhizoma sparganic 20-40 part, Rhizoma Curcumae 20-40 part, Semen Persicae 20-60 part, Radix Notoginseng 20-50 part, parching to brown stilbene 60-100 part, Rhizoma Atractylodis Macrocephalae (parched) 40-80 part, Herb Gynostemmae Pentaphylli 20-40 part, Colla Corii Asini 30-60 part, Radix Glycyrrhizae 15-30 part, Semen Pharbitidis 15-40 part, Herba Hedyotidis Diffusae 30-60 part, Radix Isatidis 30-60 part.
As preferably, formed by the component of following weight portion: fry 60 parts of Carapax Trionycis, 30 parts of Squama Manis(parched), 40 parts of Eupolyphaga Seu Steleophagas, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 40 parts in Semen Persicae, 30 parts of Radix Notoginseng, 90 parts of parching to brown stilbenes, 60 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 40 parts of Herb Gynostemmae Pentaphylli, 40 parts in Colla Corii Asini, 20 parts in Radix Glycyrrhizae, 30 parts of Semen Pharbitidiss, 50 parts of Herba Hedyotidis Diffusaes, 45 parts of Radix Isatidis.
A kind of Chinese medicine composition for the treatment of liver cirrhosis is comprised of the component of following weight portion: fry Carapax Trionycis 40-80 part, Squama Manis(parched) 20-60 part, Eupolyphaga Seu Steleophaga 20-60 part, rhizoma sparganic 20-40 part, Rhizoma Curcumae 20-40 part, Semen Persicae 20-60 part, Radix Notoginseng 20-50 part, parching to brown stilbene 60-100 part, Rhizoma Atractylodis Macrocephalae (parched) 40-80 part, Herb Gynostemmae Pentaphylli 20-40 part, Colla Corii Asini 30-60 part, Radix Glycyrrhizae 15-30 part, Semen Pharbitidis 15-40 part, Herba Hedyotidis Diffusae 30-60 part, Radix Isatidis 30-60 part, Hirudo 15-45 part, Tabanus 15-45 part.
As preferably, formed by the component of following weight portion: fry 60 parts of Carapax Trionycis, 30 parts of Squama Manis(parched), 40 parts of Eupolyphaga Seu Steleophagas, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 40 parts in Semen Persicae, 30 parts of Radix Notoginseng, 90 parts of parching to brown stilbenes, 60 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 40 parts of Herb Gynostemmae Pentaphylli, 40 parts in Colla Corii Asini, 20 parts in Radix Glycyrrhizae, 30 parts of Semen Pharbitidiss, 50 parts of Herba Hedyotidis Diffusaes, 45 parts of Radix Isatidis, 30 parts of Hirudos, 30 parts of Tabanuss.
Its dosage form is powder.
As preferably, its dosage form is electuary.
Liver cirrhosis belongs to " expansion ", " disease is long-pending " category in the traditional Chinese medical science, do not save mainly due to food and drink, and feelings will is hindered, labor is wanted excessively, infect schistosomicide and jaundice, gather to lose and control, cause all damages of liver spleen kidney or functional disorder, blood stasis is built up, retention of damp-heat in the interior, the QI and blood water knot of fighting, the general network of water is hindered, QI and blood water is tied in abdomen and to be formed abdominal part and swell, and sends out as expanding.The pathogeny of liver cirrhosis is deficiency in origin and excess in superficiality, and simulataneous insufficiency and excessive is in the majority with excess syndrome in early days, therefore take eliminating evil as main.Later stage, treatment was take strengthening vital QI to eliminate pathogenic factors as well-established law take weakened body resistance as main.
Most of liver cirrhosis patients are in " losing the compensatory phase " usually, and its common main mark disease has two: jaundice and ascites.For these two main mark diseases, western medicine, expense is high, weak curative effect.And adopt Chinese medicine composition of the present invention to treat, just can lower jaundice rapidly in general 20 to 50 days.
The inventor finds in practice, the pathological characteristic of liver cirrhosis is extensive hepatocellular degeneration or corrupted, fibrous tissue diffusivity hypertrophy, jaundice and ascites then are because hypofunction of liver and portal hypertension cause, and fibrous tissue diffusivity hypertrophy is the main cause that causes the portal hypertension hypofunction of liver.Therefore, the inventor will treat fibrous tissue diffusivity hypertrophy in the therapeutic process of liver cirrhosis.
Stir-fry Carapax Trionycis among the present invention in the component, Squama Manis(parched), Eupolyphaga Seu Steleophaga, rhizoma sparganic, Rhizoma Curcumae, Semen Persicae, Radix Notoginseng, effect with blood circulation promoting and blood stasis dispelling, softening fibre, can degrade to the liver fiber, block, heavily absorb, thereby reach the reduction portal hypertension, improve the circulation of liver inner blood, make the unobstructed effect of portal vein backflow.And parching to brown stilbene, Rhizoma Atractylodis Macrocephalae (parched), Herb Gynostemmae Pentaphylli, Colla Corii Asini, Radix Glycyrrhizae in the component then have the protection hepatocyte, improve immunity of organisms, and raising albumin is corrected albumin and the inverted effect of globulin ratio.Simultaneously, the Semen Pharbitidis in the component, Herba Hedyotidis Diffusae, Radix Isatidis have the effect that takes stopgap measures, and can effectively reduce patient's infection and corresponding complication.By the mating reaction of each component, Chinese medicine composition of the present invention can make the liver fiber of liver cirrhosis patient eliminate gradually, absorb, and the mark diseases such as ascites, jaundice also can be recovered without treatment.The present invention adopts plurality of Chinese to cooperate according to the theory of the traditional Chinese medical science " the body resistance strengthening and constitution consolidating ", can effectively treat liver cirrhosis, and its drug effect is definite simultaneously, and effect is remarkable.Aforementioned preferred version simultaneously also is that the inventor constantly gropes in the time, sums up and obtain.
Simultaneously, the inventor finds, by aforementioned proportioning, when adding Hirudo, Tabanus in the component, can greatly shorten treatment time, its effect better (every hemorrhage patient arranged, hemorrhage or bleeding tendency appears and during, all can not use).Occur in the patient body hemorrhage or when bleeding tendency occurring, can only adopt the component that does not contain Hirudo, Tabanus, in other situations, all can adopt the component that contains Hirudo, Tabanus.
The dosage form of Chinese medicine composition of the present invention can be powder or electuary, preferred electuary, and the dose of electuary is more accurate, takes conveniently, is easy to carry simultaneously.
Adopt traditional Chinese medicine composition for treating liver cirrhosis of the present invention, except the critical illness exception, most patient can be in hospital, and does not tap the abdomen, and does not perform the operation, and plasmapheresis just can not reach the expection purpose for the treatment of, thereby effectively alleviates the patient suffering.Traditional Chinese medicine composition for treating effect of the present invention is remarkable, is difficult for recurrence, can not bring wound to the patient, and expense is low, can effectively alleviate patient's financial burden.
The specific embodiment
Disclosed all features in this description, or the step in disclosed all methods or the process except mutually exclusive feature and/or step, all can make up by any way.
Disclosed arbitrary feature in this description is unless special narration all can be replaced by other equivalences or the alternative features with similar purpose.That is, unless special narration, each feature is an example in a series of equivalences or the similar characteristics.
Embodiment 1
Get respectively and fry Carapax Trionycis 80g, Squama Manis(parched) 30g, Eupolyphaga Seu Steleophaga 55g, rhizoma sparganic 40g, Rhizoma Curcumae 20g, Semen Persicae 30g, Radix Notoginseng 45g, parching to brown stilbene 100g, Rhizoma Atractylodis Macrocephalae (parched) 40g, Herb Gynostemmae Pentaphylli 28g, Colla Corii Asini 60g, Radix Glycyrrhizae 22g, Semen Pharbitidis 28g, Herba Hedyotidis Diffusae 60g, Radix Isatidis 55g.Each component is ground composition, mix, make pill.
Embodiment 2
Get respectively and fry Carapax Trionycis 50g, Squama Manis(parched) 20g, Eupolyphaga Seu Steleophaga 27g, rhizoma sparganic 21g, Rhizoma Curcumae 36g, Semen Persicae 60g, Radix Notoginseng 22g, parching to brown stilbene 72g, Rhizoma Atractylodis Macrocephalae (parched) 76g, Herb Gynostemmae Pentaphylli 40g, Colla Corii Asini 32g, Radix Glycyrrhizae 18g, Semen Pharbitidis 37g, Herba Hedyotidis Diffusae 39g, Radix Isatidis 35g.Each component is mixed, pulverize, make electuary.
Embodiment 3
Get respectively and fry Carapax Trionycis 75g, Squama Manis(parched) 40g, Eupolyphaga Seu Steleophaga 50g, rhizoma sparganic 40g, Rhizoma Curcumae 20g, Semen Persicae 35g, Radix Notoginseng 45g, parching to brown stilbene 95g, Rhizoma Atractylodis Macrocephalae (parched) 70g, Herb Gynostemmae Pentaphylli 35g, Colla Corii Asini 35g, Radix Glycyrrhizae 20g, Semen Pharbitidis 40g, Herba Hedyotidis Diffusae 55g, Radix Isatidis 50g.Each component is mixed, pulverize, make electuary.
Embodiment 4
Get respectively and fry Carapax Trionycis 60g, Squama Manis(parched) 30g, Eupolyphaga Seu Steleophaga 40g, rhizoma sparganic 30g, Rhizoma Curcumae 30g, Semen Persicae 40g, Radix Notoginseng 30g, parching to brown stilbene 90g, Rhizoma Atractylodis Macrocephalae (parched) 60g, Herb Gynostemmae Pentaphylli 40g, Colla Corii Asini 40g, Radix Glycyrrhizae 20g, Semen Pharbitidis 30g, Herba Hedyotidis Diffusae 50g, Radix Isatidis 45g.Each component is mixed, pulverize, make electuary.
Embodiment 5
Get respectively and fry Carapax Trionycis 80g, Squama Manis(parched) 25g, Eupolyphaga Seu Steleophaga 45g, rhizoma sparganic 35g, Rhizoma Curcumae 20g, Semen Persicae 25g, Radix Notoginseng 45g, parching to brown stilbene 100g, Rhizoma Atractylodis Macrocephalae (parched) 45g, Herb Gynostemmae Pentaphylli 30g, Colla Corii Asini 55g, Radix Glycyrrhizae 25g, Semen Pharbitidis 20g, Herba Hedyotidis Diffusae 60g, Radix Isatidis 55g, Hirudo 25g, Tabanus 40g.Each component is mixed, pulverize, make electuary.
Embodiment 6
Get respectively and fry Carapax Trionycis 40g, Squama Manis(parched) 45g, Eupolyphaga Seu Steleophaga 20g, rhizoma sparganic 20g, Rhizoma Curcumae 40g, Semen Persicae 60g, Radix Notoginseng 20g, parching to brown stilbene 65g, Rhizoma Atractylodis Macrocephalae (parched) 75g, Herb Gynostemmae Pentaphylli 40g, Colla Corii Asini 35g, Radix Glycyrrhizae 18g, Semen Pharbitidis 40g, Herba Hedyotidis Diffusae 35g, Radix Isatidis 40g, Hirudo 42g, Tabanus 15g.Each component is mixed, pulverize, make electuary.
Embodiment 7
Get respectively and fry Carapax Trionycis 60g, Squama Manis(parched) 30g, Eupolyphaga Seu Steleophaga 40g, rhizoma sparganic 30g, Rhizoma Curcumae 30g, Semen Persicae 40g, Radix Notoginseng 30g, parching to brown stilbene 90g, Rhizoma Atractylodis Macrocephalae (parched) 60g, Herb Gynostemmae Pentaphylli 40g, Colla Corii Asini 40g, Radix Glycyrrhizae 20g, Semen Pharbitidis 30g, Herba Hedyotidis Diffusae 50g, Radix Isatidis 45g, Hirudo 30g, Tabanus 30g.Each component is mixed, pulverize, make electuary.
Put into practice for many years by the inventor, successfully to cure several patients.After a lot of cases adopt the traditional Chinese medicine composition for treating of the present invention's preparation, obtained breakthrough effect.Model case is as follows:
Case one: week certain, suffering from liver cirrhosis in 1999 has very dark jaundice, treats near the bimester in certain medical college, spends more than 30,000 yuan, and is invalid, hospital's abandoning cure.After going home, again in other hospitalizes tens days, also invalid.Introduce through other people, medical to here, adopt medicine of the present invention to treat, patient just can have a meal after 2 days, and recovery from illness after 8 months is done manual work so far outside.
Case two: make pottery certain, the man, 35 years old, suffering from liver cirrhosis in 2010, jaundice is profound, and hospital requires it to carry out plasmapheresis, needs more than 20 ten thousand medical expenses, patient's financial insolvency.After forward here to, adopt important composition of the present invention to treat nearly 1 year, spend several thousand yuan, now fully recover.
Case three: congratulate certain, the man at suffering from liver cirrhosis in 2005, has a large amount of ascites, and large tripe is arranged.In certain medical college treatment, effect is undesirable.Congratulate after certain goes home, esophageal vein repeatedly occurs and break, and cause massive hemorrhage, for several times first aid is hospitalized for treatment, and also repeatedly receives the notice of being critically ill.See and treat patients by here, adopt traditional Chinese medicine composition for treating of the present invention after, it is hemorrhage that an esophageal vein did not appear over 7 years, ascites also disappears, is at present the state of prolonging life in spite of illness.
The present invention is not limited to the aforesaid specific embodiment.The present invention expands to any new feature or any new combination that discloses in this manual, and the arbitrary new method that discloses or step or any new combination of process.
Claims (7)
1. Chinese medicine composition for the treatment of liver cirrhosis is comprised of the component of following weight portion: fry Carapax Trionycis 40-80 part, Squama Manis(parched) 20-60 part, Eupolyphaga Seu Steleophaga 20-60 part, rhizoma sparganic 20-40 part, Rhizoma Curcumae 20-40 part, Semen Persicae 20-60 part, Radix Notoginseng 20-50 part, parching to brown stilbene 60-100 part, Rhizoma Atractylodis Macrocephalae (parched) 40-80 part, Herb Gynostemmae Pentaphylli 20-40 part, Colla Corii Asini 30-60 part, Radix Glycyrrhizae 15-30 part, Semen Pharbitidis 15-40 part, Herba Hedyotidis Diffusae 30-60 part, Radix Isatidis 30-60 part.
2. the Chinese medicine composition for the treatment of liver cirrhosis according to claim 1 is characterized in that, is comprised of the component of following weight portion: fry 60 parts of Carapax Trionycis, 30 parts of Squama Manis(parched), 40 parts of Eupolyphaga Seu Steleophagas, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 40 parts in Semen Persicae, 30 parts of Radix Notoginseng, 90 parts of parching to brown stilbenes, 60 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 40 parts of Herb Gynostemmae Pentaphylli, 40 parts in Colla Corii Asini, 20 parts in Radix Glycyrrhizae, 30 parts of Semen Pharbitidiss, 50 parts of Herba Hedyotidis Diffusaes, 45 parts of Radix Isatidis.
3. the Chinese medicine composition for the treatment of liver cirrhosis according to claim 1 and 2 is characterized in that, its dosage form is powder.
4. the Chinese medicine composition for the treatment of liver cirrhosis according to claim 1 and 2 is characterized in that, its dosage form is electuary.
5. Chinese medicine composition for the treatment of liver cirrhosis is comprised of the component of following weight portion: fry Carapax Trionycis 40-80 part, Squama Manis(parched) 20-60 part, Eupolyphaga Seu Steleophaga 20-60 part, rhizoma sparganic 20-40 part, Rhizoma Curcumae 20-40 part, Semen Persicae 20-60 part, Radix Notoginseng 20-50 part, parching to brown stilbene 60-100 part, Rhizoma Atractylodis Macrocephalae (parched) 40-80 part, Herb Gynostemmae Pentaphylli 20-40 part, Colla Corii Asini 30-60 part, Radix Glycyrrhizae 15-30 part, Semen Pharbitidis 15-40 part, Herba Hedyotidis Diffusae 30-60 part, Radix Isatidis 30-60 part, Hirudo 15-45 part, Tabanus 15-45 part.
6. the Chinese medicine composition for the treatment of liver cirrhosis according to claim 5 is characterized in that, is comprised of the component of following weight portion: fry 60 parts of Carapax Trionycis, 30 parts of Squama Manis(parched), 40 parts of Eupolyphaga Seu Steleophagas, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 40 parts in Semen Persicae, 30 parts of Radix Notoginseng, 90 parts of parching to brown stilbenes, 60 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 40 parts of Herb Gynostemmae Pentaphylli, 40 parts in Colla Corii Asini, 20 parts in Radix Glycyrrhizae, 30 parts of Semen Pharbitidiss, 50 parts of Herba Hedyotidis Diffusaes, 45 parts of Radix Isatidis, 30 parts of Hirudos, 30 parts of Tabanuss.
7. according to claim 5 or the Chinese medicine composition of 6 described treatment liver cirrhosis, it is characterized in that, its dosage form is powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210422681.1A CN102895599B (en) | 2012-10-30 | 2012-10-30 | Traditional Chinese medical composition for treatment of cirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210422681.1A CN102895599B (en) | 2012-10-30 | 2012-10-30 | Traditional Chinese medical composition for treatment of cirrhosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102895599A true CN102895599A (en) | 2013-01-30 |
| CN102895599B CN102895599B (en) | 2014-03-05 |
Family
ID=47568284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210422681.1A Expired - Fee Related CN102895599B (en) | 2012-10-30 | 2012-10-30 | Traditional Chinese medical composition for treatment of cirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895599B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108653685A (en) * | 2018-08-31 | 2018-10-16 | 李华桥 | A kind of Chinese medicine composition and preparation method thereof for treating hepatic sclerosis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1253013A (en) * | 1999-10-25 | 2000-05-17 | 车兴泉 | Medicine for treating hepatism and its preparing process |
| CN1279074A (en) * | 2000-05-19 | 2001-01-10 | 李隆伟 | Chinese-medicinal pill 'Ganxuetong' |
| CN1486736A (en) * | 2003-08-19 | 2004-04-07 | 黄资源 | Fibrillation-resisting liver softening bolus as compound Chinese medicine prepn for treating fibrillation and cirthosis of liver |
| CN101612360A (en) * | 2009-07-17 | 2009-12-30 | 肖嘉惠 | The medicine of treatment hepatitis, liver cirrhosis, hepatocarcinoma |
-
2012
- 2012-10-30 CN CN201210422681.1A patent/CN102895599B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1253013A (en) * | 1999-10-25 | 2000-05-17 | 车兴泉 | Medicine for treating hepatism and its preparing process |
| CN1279074A (en) * | 2000-05-19 | 2001-01-10 | 李隆伟 | Chinese-medicinal pill 'Ganxuetong' |
| CN1486736A (en) * | 2003-08-19 | 2004-04-07 | 黄资源 | Fibrillation-resisting liver softening bolus as compound Chinese medicine prepn for treating fibrillation and cirthosis of liver |
| CN101612360A (en) * | 2009-07-17 | 2009-12-30 | 肖嘉惠 | The medicine of treatment hepatitis, liver cirrhosis, hepatocarcinoma |
Non-Patent Citations (3)
| Title |
|---|
| 周东红: "补血汤治疗肝硬化脾功能亢进的临床观察", 《中外医疗》 * |
| 周强，张家成，赵锡艳，仝小林1: "仝小林教授治疗肝硬化方药介绍", 《世界中西医结合杂志》 * |
| 张学华，张群，王蓓: "水蛭、虻虫、土鳖虫临床如何区别应用", 《中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108653685A (en) * | 2018-08-31 | 2018-10-16 | 李华桥 | A kind of Chinese medicine composition and preparation method thereof for treating hepatic sclerosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102895599B (en) | 2014-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
| CN103007226A (en) | Drug for treating hepatocirrhosis ascites, and preparation method thereof | |
| CN102895599B (en) | Traditional Chinese medical composition for treatment of cirrhosis | |
| CN102274445A (en) | Cassia twig common burreed rhizome tumor eliminating pills | |
| CN104857188A (en) | Traditional Chinese medicine composite for treating edema | |
| CN104547933A (en) | Traditional Chinese medicine composition as well as preparation method and application thereof | |
| CN104888104B (en) | One kind is for cirsoid pharmaceutical composition of nursing for treating and preparation method thereof | |
| CN102920862A (en) | Chinese medicinal composition for treating ascites due to cirrhosis | |
| CN103191229B (en) | Traditional Chinese medicine for treating swelling of knee joints | |
| CN104436121B (en) | It is a kind of to treat irregular menstruation, small distention and fullness in the abdomen, the medicine to fail to be impregnated for a long time | |
| CN102961674A (en) | Chinese medicinal composition for treating jaundice | |
| CN104667064A (en) | Traditional Chinese medicinal composition for treating haemorrhoids | |
| CN104706862A (en) | Traditional Chinese medicine composition for treating rheumatic and rheumatoid bone diseases and preparation method of traditional Chinese medicine composition | |
| CN108498622A (en) | A kind of Chinese medicine composition for treating coronary heart disease | |
| CN106266621A (en) | A kind of Chinese medicine composition treating cirrhotic ascites | |
| CN106389598A (en) | Traditional Chinese medicine composition for curing purpura | |
| CN105833230B (en) | A kind of herbal composite and preparation method thereof for treating ovarian cyst | |
| CN105727076A (en) | Traditional Chinese medicine composition for treating chronic diarrhea | |
| CN103861038B (en) | A kind of Chinese medicine for the treatment of liver depression blood-heat syndrome type preceded menstural cycle | |
| CN105079477A (en) | Traditional Chinese medicine composition for treating various haemorrhoids | |
| CN104352992A (en) | Traditional Chinese medicine composition for treating susceptible intestinal obstruction after colon tumor operation | |
| CN104258054A (en) | Traditional Chinese medicine for treating spleen-deficiency syndrome type menstruation-related diarrhea | |
| CN107569656A (en) | Treat Chinese medicine preparation and the preparation of sprain of ankle joint | |
| CN102302726A (en) | Chinese medicinal preparation for treating radiation proctitis | |
| CN106581296A (en) | Traditional Chinese medicine formula for treating diabetic retinopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140305 Termination date: 20151030 |
|
| EXPY | Termination of patent right or utility model |